Our founders’ insights and achievements

Minoryx Therapeutics Initiates Phase 1 clinical trial of MIN-102

Stat Diagnostica announces 25 Million Euros in Series C Financing

”la Caixa” leads an investment round in Inbiomotion with the participation of Ysios Capital

Minoryx Therapeutics appoints Dr. Khalid Islam as chairman of the board of directors

Aelix Therapeutics completes Series A funding of €11.5M ($12.7M) for therapeutic HIV vaccine

PlantResponse Biotech raises 5.7 Million € in Series A funding

Minoryx Therapeutics completes Series A funding of €19.4M ($21.7M)

Sanifit raises €36.6M ($41.3M) in Series C financing round

”la Caixa” leads a 1.6 million Euro round in Minoryx